The global oxygen therapy market size attained a value of USD 35.7 billion in 2023. The market is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to attain a value of USD 69.4 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
According to the World Health Organisation (WHO), more than 1 billion people in the world suffer from chronic respiratory issues. The rising cases of chronic obstructive pulmonary disease (COPD) caused by rising pollution levels and tobacco smoking are increasing the demand for supplement oxygen to improve survival chances and improve the quality of life of the patients. This is augmenting the growth of the oxygen therapy industry. Moreover, the rising awareness regarding hypoxaemia, which is one of the leading causes of child deaths worldwide, requires the use of supplement oxygen and is further boosting the market growth. The increasing efforts by UNICEF to provide oxygen concentrators in various countries are also aiding the market growth.
The growing geriatric population in Europe who are more prone to respiratory problems is providing further impetus to the market growth. Moreover, the introduction of favourable government incentives to aid the treatment of chronic illness and provide required supplement oxygen are further invigorating the market growth. Furthermore, increasing innovations to provide personalised and efficient oxygen therapy at home is also fuelling the industry growth. The market in North America is rapidly growing owing to escalating research and development (R&D) and the adoption of the latest technological advancements by the leading companies. Moreover, they are investing in digital marketing and expanding their online presence, which is also accelerating the industry growth, further contributing to the overall market growth.
Oxygen therapy, variously known as supplement oxygen, is a treatment that provides oxygen to patients with breathing disorders. It aids in improving the energy level, sleep, and quality of life of patients. Oxygen can be supplied through various ways, including face masks, nasal cannula, and bag valve masks, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the products, the market is divided into:
The major applications of oxygen therapy are:
The market can be broadly categorised on the basis of its end uses into:
The EMR report looks into the regional markets of oxygen therapy like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The demand for oxygen therapy is increasing significantly due to the surge of the coronavirus pandemic. As COVID-19 can lead to pneumonia and make it difficult or impossible to breathe, patients require supplement oxygen, which is augmenting the market growth. The escalating demand for oxygen supplements in hospitals due to the pandemic is further aiding the market. Moreover, the development of COVID speciality hospitals in various countries to contain the virus is also increasing the demand for oxygen therapy, consequently propelling the market growth. In addition, the growing demand for portable oxygen concentrators for patients in home isolation is further driving the market growth.
The surge of the second wave of the pandemic in various countries, such as India, Laos, Nepal, Singapore, South Africa, and Cambodia, among others, is resulting in the mutations of the virus and the development of deadlier strains, which, in turn, is increasing the demand for oxygen supplements, consequently facilitating the market growth. The increasing investments by the governments and major companies to aid the demand for oxygen cylinders and concentrators are also boosting the market growth. Moreover, with the rising technological advancements and the adoption of innovative practices, major companies are developing superior oxygen therapy for home healthcare. The companies are investing in research and development (R&D) to develop cost-effective, disposable, risk-free, and advanced products for oxygen therapy. This is expected to catalyse the market growth further.
The report presents a detailed analysis of the following key players in the global oxygen therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product Type||
|Breakup by Applications||
|Breakup by End User||
|Breakup by Region||
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Oxygen Therapy Market Overview
3.1 Global Oxygen Therapy Market Historical Value (2017-2023)
3.2 Global Oxygen Therapy Market Forecast Value (2024-2032)
4 Global Oxygen Therapy Market Landscape
4.1 Global Oxygen Therapy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Oxygen Therapy Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Oxygen Therapy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Oxygen Therapy Market Segmentation
6.1 Global Oxygen Therapy Market by Product Type
6.1.1 Market Overview
6.1.2 Oxygen Source Equipment
18.104.22.168 Oxygen Cylinders
22.214.171.124 Oxygen Concentrators
126.96.36.199 Liquid Oxygen Devices
188.8.131.52 PAP Devices
6.1.3 Oxygen Delivery Devices
184.108.40.206 Oxygen Masks
220.127.116.11 Nasal Cannula
18.104.22.168 Venturi Masks
22.214.171.124 Non-rebreather Masks
126.96.36.199 Bag Valve Masks
188.8.131.52 CPAP Masks
6.2 Global Oxygen Therapy Market by Applications
6.2.1 Market Overview
6.2.2 Chronic Obstructive Pulmonary Disease
6.2.4 Obstructive Sleep Apnea
6.2.5 Respiratory Distress Syndrome
6.2.6 Cystic Fibrosis
6.3 Global Oxygen Therapy Market by End User
6.3.1 Market Overview
6.3.4 Rehab Centers
6.3.5 Home Healthcare
6.3.6 Non-home Healthcare
6.4 Global Oxygen Therapy Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Oxygen Therapy Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Oxygen Therapy Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Oxygen Therapy Market
9.1 Market Share by Country
10 Latin America Oxygen Therapy Market
10.1 Market Share by Country
11 Middle East and Africa Oxygen Therapy Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 General Electric
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Tecno-Gaz S.p.A
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Koninklijke Philips N.V.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 DeVilbiss Healthcare LLC
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Smith Group plc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Allied Healthcare Products, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Teleflex Incorporated
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Invacare Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Thermo Fisher Scientific Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Essex Industries, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 OxyBand Technologies
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Nidek Medical Products, Inc
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
18 Global Oxygen Therapy Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The oxygen therapy market was valued at USD 35.7 billion in 2023.
The market is expected to grow at a CAGR of 7.7% from 2024 to 2032 to reach a value of USD 69.4 billion by 2032.
The market is being aided by the rising cases of chronic respiratory diseases, which requires supplement oxygen for the wellbeing of patients.
The market is driven by increasing research and development (R&D) by the leading players, the rising prevalence of portable oxygen concentrators, and the surging cases of pneumonia during the coronavirus pandemic.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of oxygen therapy in the industry are oxygen source equipment and oxygen delivery devices.
The dominant applications of oxygen therapy are chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, and cystic fibrosis, among others.
The significant end uses in the market are home healthcare and hospitals.
The major players in the industry are Hersill S.L., Philips Respironics, Inc., DeVilbiss Healthcare LLC, Smiths Group plc, and Teleflex Incorporated, among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.